| | Healthcare Industry | Hospitals
Accountability for Hospital-Acquired Invasive Fungal Infections: A Systems Analysis
Shared Responsibility in Preventing HA-IFIs
Hospital-acquired invasive fungal infections (HA-IFIs)—candidemia, aspergillosis, mucormycosis—carry high mortality (30–60%). Attributing responsibility requires a systems view, not individual blame.
Stakeholder Roles & Accountabilities
| Stakeholder | Primary Responsibilities | Accountability Mechanisms |
|---|---|---|
| Physicians (Attending, Fellows, Residents) | Risk assessment; antifungal stewardship (prophylaxis/empiric/preemptive); early diagnosis (biomarkers, imaging); source control | Peer review, morbidity/mortality conference, credentialing, antifungal use audits |
| Nurses (Bedside, ICN, Transplant) | Central line care (CLABSI prevention); skin/mucosal integrity; hand hygiene compliance; early symptom recognition; patient education | Unit-based audits, CLABSI rates, competency validation, shared governance |
| Respiratory Therapists | Ventilator circuit hygiene; humidifier management; suction technique; aerosolized antifungal delivery; equipment reprocessing | VAP bundles, equipment culture surveillance, competency checks |
| Infection Preventionists (IPs) | Surveillance (NHSN); outbreak investigation; bundle implementation; construction/renovation ICRA; antifungal resistance tracking | HAI rate reporting, CMS/Leapfrog scores, Joint Commission standards |
| Pharmacists (Antimicrobial Stewardship) | Formulary management; TDM (voriconazole, posaconazole); IV-to-PO conversion; drug interactions; cost-effectiveness | ASP metrics (days of therapy, resistance, cost), P&T committee |
| Environmental Services (EVS) | Terminal cleaning (sporicidal agents); HEPA filtration; construction barriers; water system management (Legionella, molds) | ATP monitoring, fluorescent gel audits, air/water sampling |
| Hospital Administration | Resource allocation (staffing, diagnostics, antifungals); culture of safety; capital investment (HEPA, single rooms); policy enforcement | Board quality committees, C-suite dashboards, regulatory compliance |
| Patients/Families | Hand hygiene adherence; reporting concerns; isolation compliance; medication adherence | Education materials, patient advisory councils, speak-up campaigns |
Systemic Failure Points
- Communication gaps during handoffs/transfers
- Delayed diagnostics (non-culture biomarkers underused)
- Inadequate prophylaxis in high-risk units (ICU, transplant, heme-malig)
- Construction without ICRA → Aspergillus outbreaks
- Antifungal stewardship gaps → resistance (C. auris, azole-resistant Aspergillus)
High-Reliability Approach
- Multidisciplinary HA-IFI prevention committee.
- Real-time surveillance with automated alerts.
- Bundle compliance dashboards (central line, ventilator, surgical).
- Just culture: report near-misses without fear.
- Continuous simulation training for rare events.
No single party "owns" HA-IFI prevention. It is a collective, interdependent obligation requiring leadership commitment, transparent data, and empowered frontline staff.
Hospitals - Related Articles
- Hospital Management System (HMS) - Software Requirements Specification
- Involuntary Hospitalization: Legal Grounds and Patient Rights
- Who Owns Community Hospitals? Nonprofit vs. For-Profit Models
- Hospital Concierge: Roles, Responsibilities & Patient Experience
- Donate Hearing Aids in Arizona: Find Local Donation Centers
- Professional Roles and Responsibilities in Multi-Specialty Hospitals
- Understanding and Measuring Stroke Severity: The NIH Stroke Scale
